Gold Investment Management’s AbbVie ABBV Stock Holding History

Gold Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.02M	Sell	8,043 -46	-0.6%	-$9.9K	0.55%	59
2026 Q1	$1.76M	Buy	8,089 +21	+0.3%	+$4.66K	0.54%	61
2025 Q4	$1.84M	Sell	8,068 -4	-0%	-$911	0.59%	59
2025 Q3	$1.87M	Buy	8,072 +8	+0.1%	+$1.63K	0.63%	57
2025 Q2	$1.51M	Buy	8,064 +26	+0.3%	+$4.83K	0.57%	61
2025 Q1	$1.68M	Buy	8,038 +63	+0.8%	+$12.2K	0.71%	58
2024 Q4	$1.42M	Buy	7,975 +3	+0%	+$552	0.6%	60
2024 Q3	$1.56M	Sell	7,972 -3,090	-28%	-$577K	0.65%	58
2024 Q2	$1.9M	Sell	11,062 -1,111	-9%	-$184K	0.8%	48
2024 Q1	$2.22M	Sell	12,173 -780	-6%	-$134K	0.9%	43
2023 Q4	$2.01M	Buy	+12,953	New	+$1.89M	0.86%	45

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gold Investment Management's ABBV Position: Q2 2026 in Review

Gold Investment Management reduced its AbbVie (ABBV) stake by 0.57% in Q2 2026, selling an estimated $9.9K and leaving 8,043 shares worth $2.02M. The position accounts for 0.55% of the portfolio, ranked #59.

Gold Investment Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.22M in Q1 2024. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Gold Investment Management held 8,043 shares of AbbVie worth $2.02M as of Q2 2026.
Gold Investment Management sold 46 AbbVie shares in Q2 2026, an estimated $9.9K.
AbbVie made up 0.55% of Gold Investment Management's portfolio in Q2 2026, its #59 holding.
Gold Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Gold Investment Management's AbbVie position peaked at $2.22M in Q1 2024.
4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gold Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.